Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regions Financial | RF | Dec 31, 2024 | 23.52 | -0.59 |
Regions Financial B Pref | RF-B | Dec 31, 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Dec 31, 2024 | 24.24 | +0.87 |
Regions Financial E Pref | RF-E | Dec 31, 2024 | 17.77 | +0.40 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Dec 31, 2024 | 26.24 | +0.96 |
Regis | RGS | Dec 31, 2024 | 23.72 | -5.12 |
Regulus Therapeutics | RGLS | Dec 31, 2024 | 1.58 | +5.33 |
Reinsurance Group of America | RGA | Dec 31, 2024 | 213.63 | +0.58 |
REIT Index ETF Vanguard | VNQ | Dec 31, 2024 | 89.08 | +0.87 |
Reitar Logtech | RITR | Dec 31, 2024 | 3.74 | -4.35 |
Rekor Systems | REKR | Dec 31, 2024 | 1.56 | -16.13 |
Relay Therapeutics | RLAY | Dec 31, 2024 | 4.12 | -1.44 |
Reliance | RS | Dec 31, 2024 | 269.26 | +1.14 |
Reliance Global | RELI | Dec 31, 2024 | 2.58 | -0.39 |
Relmada Therapeutics | RLMD | Dec 31, 2024 | 0.52 | +13.29 |
RELX ADR | RELX | Dec 31, 2024 | 45.42 | +0.04 |
Remitly Global | RELY | Dec 31, 2024 | 22.57 | -0.57 |
Renaissance Ipo ETF | IPO | Dec 31, 2024 | 43.57 | -1.29 |
RenaissanceRe | RNR | Dec 31, 2024 | 248.81 | +0.00 |
RenaissanceRe G Pref | RNR-G | Dec 31, 2024 | 16.58 | -1.25 |
RenaissanceRe Holding F Pref | RNR-F | Dec 31, 2024 | 22.41 | -0.44 |
Renalytix ADR | RNLX | Dec 31, 2024 | 0.20 | 0.00 |
Renasant | RNST | Dec 31, 2024 | 35.75 | +0.03 |
ReNew Energy Global A Shares | RNW | Dec 31, 2024 | 6.83 | -1.59 |
Renn Fund | RCG | Dec 31, 2024 | 2.23 | -1.76 |
Renovaro Biosciences | RENB | Dec 31, 2024 | 0.84 | -4.03 |
RenovoRx | RNXT | Dec 31, 2024 | 1.29 | -7.19 |
Rent The Runway A | RENT | Dec 31, 2024 | 8.50 | -3.85 |
Rentokil Initial ADR | RTO | Dec 31, 2024 | 25.32 | +1.08 |
Repare Therapeutics | RPTX | Dec 31, 2024 | 1.31 | +4.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.